1. Home
  2. ERH vs PYPD Comparison

ERH vs PYPD Comparison

Compare ERH & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Utilities and High Income Fund

ERH

Allspring Utilities and High Income Fund

N/A

Current Price

$10.21

Market Cap

90.5M

Sector

Finance

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.37

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERH
PYPD
Founded
2004
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
107.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ERH
PYPD
Price
$10.21
$5.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.75
AVG Volume (30 Days)
21.1K
★ 78.9K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 8.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.16
$3.06
52 Week High
$13.07
$5.73

Technical Indicators

Market Signals
Indicator
ERH
PYPD
Relative Strength Index (RSI) 31.68 56.33
Support Level N/A $4.15
Resistance Level $11.69 $5.59
Average True Range (ATR) 0.15 0.23
MACD -0.02 -0.01
Stochastic Oscillator 22.02 76.44

Price Performance

Historical Comparison
ERH
PYPD

About ERH Allspring Utilities and High Income Fund

Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: